1. Peacock, AJ, Murphy, NF, McMurray, JJ, Caballero, L, Stewart, S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J. 2007;30(1):104-109.
Google Scholar | Crossref | Medline | ISI2. Humbert, M, Sitbon, O, Chaouat, A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006;173(9):1023-1030.
Google Scholar | Crossref | Medline | ISI3. Badesch, DB, Raskob, GE, Elliott, CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010;137(2):376-387.
Google Scholar | Crossref | Medline | ISI4. Ling, Y, Johnson, MK, Kiely, DG, et al. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am J Respir Crit Care Med. 2012;186(8):790-796.
Google Scholar | Crossref | Medline | ISI5. McGoon, MD, Benza, RL, Escribano-Subias, P, et al. Pulmonary arterial hypertension: epidemiology and registries. J Am College Cardiol. 2013;62(25 suppl):D51-D59.
Google Scholar | Crossref | Medline6. Tonelli, AR, Arelli, V, Minai, OA, et al. Causes and circumstances of death in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2013;188(3):365-369.
Google Scholar | Crossref | Medline | ISI7. Hoeper, MM, Benza, RL, Corris, P, et al. Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension. Eur Respir J. 2019;53(1).
Google Scholar | Crossref8. Jentzer, JC, Mathier, MA. Pulmonary hypertension in the intensive care unit. J Intensive Care Med. 2016;31(6):369-385.
Google Scholar | SAGE Journals | ISI9. Tejwani, V, Patel, DC, Zein, J, et al. Survival after an ICU hospitalization for pulmonary hypertension. Chest. 2018;154(1):229-231.
Google Scholar | Crossref | Medline10. D’Alonzo, GE, Barst, RJ, Ayres, SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991;115(5):343-349.
Google Scholar | Crossref | Medline | ISI11. Delcroix, M, Naeije, R. Optimising the management of pulmonary arterial hypertension patients: emergency treatments. Eur Respir Rev. 2010;19(117):204-211.
Google Scholar | Crossref | Medline12. Campo, A, Mathai, SC, Le Pavec, J, et al. Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension. Eur Respir J. 2011;38(2):359-367.
Google Scholar | Crossref | Medline | ISI13. Haddad, F, Peterson, T, Fuh, E, et al. Characteristics and outcome after hospitalization for acute right heart failure in patients with pulmonary arterial hypertension. Circ Heart Fail. 2011;4(6):692-699.
Google Scholar | Crossref | Medline | ISI14. Hoeper, MM, Galie, N, Murali, S, et al. Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med. 2002;165(3):341-344.
Google Scholar | Crossref | Medline | ISI15. Huynh, TN, Weigt, SS, Sugar, CA, Shapiro, S, Kleerup, EC. Prognostic factors and outcomes of patients with pulmonary hypertension admitted to the intensive care unit. J Crit Care. 2012;27(6):739.e7-13.
Google Scholar | Crossref | Medline | ISI16. Sztrymf, B, Souza, R, Bertoletti, L, et al. Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension. Eur Respir J. 2010;35(6):1286-1293.
Google Scholar | Crossref | Medline | ISI17. Sitbon, O, Morrell, N. Pathways in pulmonary arterial hypertension: the future is here. Eur Respir Rev. 2012;21(126):321-327.
Google Scholar | Crossref | Medline18. Guignabert, C, Tu, L, Le Hiress, M, et al. Pathogenesis of pulmonary arterial hypertension: lessons from cancer. Eur Respir Rev. 2013;22(130):543-551.
Google Scholar | Crossref | Medline19. Tonelli, AR, Zein, J, Ioannidis, JP. Geometry of the randomized evidence for treatments of pulmonary hypertension. Cardiovasc Ther. 2013;31(6):e138-46.
Google Scholar | Crossref | Medline20. Narechania, S, Torbic, H, Tonelli, AR. Treatment discontinuation or interruption in pulmonary arterial hypertension. J Cardiovascu Pharmacol Ther. 2020;25(2):131-141.
Google Scholar | SAGE Journals | ISI21. Keogh, AM, Jabbour, A, Hayward, CS, Macdonald, PS. Clinical deterioration after sildenafil cessation in patients with pulmonary hypertension. Vasc Health Risk Manage. 2008;4(5):1111-1113.
Google Scholar | Medline22. Christenson, J, Lavoie, A, O’Connor, M, Bhorade, S, Pohlman, A, Hall, JB. The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide. Am J Respir Crit Care Med. 2000;161(5):1443-1449.
Google Scholar | Crossref | Medline23. Augoustides John, G, Culp, K, Smith, S. Rebound pulmonary hypertension and cardiogenic shock after withdrawal of inhaled prostacyclin. Anesthesiology. 2004;100(4):1023-1025.
Google Scholar | Crossref | Medline24. Chebib, N, Cottin, V, Taharo-Ag-Ralissoum, M, Chuzeville, M, Mornex, JF. Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem. Pulm Circ. 2018;8(1):2045893217753352.
Google Scholar | SAGE Journals | ISI25. Smith, BS, Yogaratnam, D, Levasseur-Franklin, KE, Forni, A, Fong, J. Introduction to drug pharmacokinetics in the critically ill patient. Chest. 2012;141(5):1327-1336.
Google Scholar | Crossref | Medline | ISI26. Torbic, H . Management of pulmonary arterial hypertension in the ICU. J Pharm Pract. 2019;32(3):303-313.
Google Scholar | SAGE Journals | ISI27. Harris, KW, O’Riordan, TG, Smaldone, GC. Aerosolized iloprost customized for the critically ill. Respir Care. 2007;52(11):1507-1509.
Google Scholar | Medline | ISI28. Parker, DK, Shen, S, Zheng, J, et al. Inhaled treprostinil drug delivery during mechanical ventilation and spontaneous breathing using two different nebulizers. Pediatr Crit Care Med. 2017;18(6):e253-e260.
Google Scholar | Crossref | Medline29. Dhand, R, Tobin, MJ. Inhaled bronchodilator therapy in mechanically ventilated patients. Am J Respir Crit Care Med. 1997;156(1):3-10.
Google Scholar | Crossref | Medline | ISI30. McGinn, K, Reichert, M. A comparison of inhaled nitric oxide versus inhaled epoprostenol for acute pulmonary hypertension following cardiac surgery. Ann Pharmacotherapy. 2016;50(1):22-26.
Google Scholar | SAGE Journals | ISI31. Huang, J, Fridman, D. High flow oxygen and low dose inhaled nitric oxide in a case of severe pulmonary hypertension and obstructive shock. Chest. 2011;140(4):63A.
Google Scholar | Crossref32. Tonelli, AR, Alnuaimat, H, Mubarak, K. Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension. Respir Med. 2010;104(4):481-496.
Google Scholar | Crossref | Medline | ISI33. Tonelli, AR, Haserodt, S, Aytekin, M, Dweik, RA. Nitric oxide deficiency in pulmonary hypertension: pathobiology and implications for therapy. Pulm Circ. 2013;3(1):20-30.
Google Scholar | SAGE Journals | ISI34. Vonbank, K, Ziesche, R, Higenbottam, TW, et al. Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD. Thorax. 2003;58(4):289-293.
Google Scholar | Crossref | Medline | ISI35. Pérez-Peñate, GM, Juliá-Serdà, G, Ojeda-Betancort, N, et al. Long-term inhaled nitric oxide plus phosphodiesterase 5 inhibitors for severe pulmonary hypertension. J Heart Lung Transplant. 2008;27(12):1326-1332.
Google Scholar | Crossref | Medline36. Heuts, S, Ubben, JF, Banks-Gonzales, V, et al. Nitric oxide ventilation improves recirculation and right ventricular function during veno-venous extracorporeal membrane oxygenation in a COVID-19 patient. J Cardiothorac Vascu Anesthesia. 2021;35(9):2763-2767.
Google Scholar | Crossref | Medline37. Tooba, R, Almoushref, A, Tonelli, AR. Is there value in repeating inhaled nitric oxide vasoreactivity tests in patients with pulmonary arterial hypertension? Lung. 2020;198(1):87-94.
Google Scholar | Crossref | Medline38. Hoffman, GM, Ross, GA, Day, SE, Rice, TB, Nelin, LD. Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn. Crit Care Med. 1997;25(2):352-359.
Google Scholar | Crossref | Medline39. Torbic, H, Szumita, PM, Anger, KE, Nuccio, P, LaGambina, S, Weinhouse, G. Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients. J Crit Care. 2013;28(5):844-848.
Google Scholar | Crossref | Medline | ISI40. Kingman, MS, Chin, K. Safety recommendations for administering intravenous prostacyclins in the hospital. Crit Care Nurse. 2013;33(5):32-39.
Google Scholar | Crossref | Medline41. Alkukhun, L, Bair, ND, Dweik, RA, Tonelli, AR. Subcutaneous to intravenous prostacyclin analog transition in pulmonary hypertension. J Cardiovasc Pharmacol. 2014;63(1):4-8.
Google Scholar | Crossref | Medline | ISI42. Horvatits, T, Drolz, A, Trauner, M, Fuhrmann, V. Liver injury and failure in critical illness. Hepatology. 2019;70(6):2204-2215.
Google Scholar | Crossref | Medline43. Case, J, Khan, S, Khalid, R, Khan, A. Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Pract. 2013;2013:479730.
Google Scholar | Medline44. Oh, DK, Shim, TS, Jo, KW, et al. Right ventricular assist device with an oxygenator using extracorporeal membrane oxygenation as a bridge to lung transplantation in a patient with severe respiratory failure and right heart decompensation. Acute Crit Care. 2020;35(2):117-121.
Google Scholar | Crossref | Medline45. Reeb, J, Olland, A, Renaud, S, et al. Vascular access for extracorporeal life support: tips and tricks. J Thoracic Dis. 2016;8(suppl 4):S353-S363.
Google Scholar | Crossref | Medline46. Makdisi, G, Wang, IW. Extra corporeal membrane oxygenation (ECMO) review of a lifesaving technology. J Thoracic Dis. 2015;7(7):E166-E176.
Google Scholar | Medline47. Dallefeld, SH, Sherwin, J, Zimmerman, KO, Watt, KM. Dexmedetomidine extraction by the extracorporeal membrane oxygenation circuit: results from an in vitro study. Perfusion. 2020;35(3):209-216.
Google Scholar | SAGE Journals | ISI48. Shekar, K, Fraser, JF, Smith, MT, Roberts, JA. Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation. J Crit Care. 2012;27(6):741.e9-18.
Google Sch